Contractor directoryCompany profile
Explore awardsCompareFollowSave company

Federal contractor profile

SIRO DIAGNOSTICS, INC.

UEI CM9UQ5VFMTZ3CAGE 03S18

Active
Small Business

Overview

Legal name
SIRO DIAGNOSTICS, INC.
Registered location
SAN DIEGO, CA, USA
Primary NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
Latest award activity
Jun 18, 2026
Read company summary

SIRO DIAGNOSTICS, INC. is associated with UEI CM9UQ5VFMTZ3 and CAGE 03S18 in public federal records. AcornBids currently links 1 prime award totaling $28.3M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as In-Vitro Diagnostic Substance Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325413 (In-Vitro Diagnostic Substance Manufacturing). Its public SAM.gov registration lists SAN DIEGO, CA, USA.

At a glance

Lifetime prime obligations$28.3M
Prime awards1
Awards with future end dates0
Top-agency concentration100.0%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 20, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name
SIRO DIAGNOSTICS, INC.
UEI
CM9UQ5VFMTZ3
CAGE
03S18
Registered address
9877 WAPLES ST, SAN DIEGO, CA, 92121, USA
Registration status
Active
Primary NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
SAM activation
Sep 9, 2025
Initial registration
Sep 18, 2024
Entity start
Aug 16, 2024
SAM updated
Sep 11, 2025
Registration expires
Sep 9, 2026
Fiscal year end
Dec 31
Place of incorporation
DE, USA

View SAM.gov source

Research brief

Source facts

  • Loaded prime-award records link 1 awards and $28,341,000 in reported obligations to this legal entity. Source
  • Recorded awards include In-Vitro Diagnostic Substance Manufacturing (NAICS 325413); this classification is not proof of every company capability. Source
  • An example award describes: ADVANCED DEVELOPMENT OF A NAAT MULTIPLEX RESPIRATORY PATHOGEN TEST FOR PROFESSIONAL POINT-OF- CARE (CLIA WAIVED) AND AT-HOME OTC USE WITH THE CUE HEALTH MONITORING SYSTEM (READER) AND CUE SAMPLE WAND Source

Federal award analysis

Net transaction obligations by federal fiscal period.

Selected transaction obligations$28.3M
Prime contracts
$28.3MFY2023$0FY2025$0FY2026

Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Histories follow awards currently assigned to this recipient and may include transactions under an earlier recipient. Coverage: 1 of 1 selected awards. Select a period to explore its awards.

Explore funding & geography →View quarterly funding

Funding change

Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.

MeasureReported value
Current periodOct 1, 2025 – Sep 30, 2026
Current obligations$0
Prior periodOct 1, 2024 – Sep 30, 2025
Prior obligations$0
Change$0
GrowthNot comparable

Where the work is performed

AKMEVTNHWAIDMTNDMNWIMINYMAORNVWYSDIAILINOHPANJCTRICAUTCONEMOKYWVVAMDDEAZNMKSARTNNCSCDCOKLAMSALGAHITXFL

State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.

Agencies
CategoryPeriod obligationsAwards
Department of Health and Human Services$28.3M1
Offices
CategoryPeriod obligationsAwards
BARDA - ASPR / DAAPPO / BARDA DCMA$28.3M1
Naics
CategoryPeriod obligationsAwards
325413 — In-Vitro Diagnostic Substance Manufacturing$28.3M1
Psc
CategoryPeriod obligationsAwards
AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT$28.3M1
Vehicles
CategoryPeriod obligationsAwards
Unclassified$28.3M1
States
CategoryPeriod obligationsAwards
CA$28.3M1
Set Asides
CategoryPeriod obligationsAwards
NO SET ASIDE USED.$28.3M1

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / descriptionAwarding agencyObligationsStart dateEnd date
75A50123C00036ADVANCED DEVELOPMENT OF A NAAT MULTIPLEX RESPIRATORY PATHOGEN TEST FOR PROFESSIONAL POINT-OF- CARE (CLIA WAIVED) AND AT-HOME OTC USE WITH THE CUE HEALTH MONITORING SYSTEM…Department of Health and Human Services$28.3MAug 2, 2023Sep 30, 2026
Explore, filter and export all awards →SubcontractsGrants & subgrants

Registration, certifications & contacts

Registration evidenceDate
SAM updatedSep 11, 2025
Source loadedSep 26, 2026
Initial registrationSep 18, 2024
Entity startAug 16, 2024

Registration classifications: Small Business. These are separate from the reported certificates above.

IndustryReported size status
325413 — In-Vitro Diagnostic Substance ManufacturingNot reported
ContactRolePublished contact methodsEvidenceSource date
JESSIE WICKGovernment businessContact method not publishedSAM registrationNot available
JESSIE WICKAlternate government businessContact method not publishedSAM registrationNot available
JESSIE WICKElectronic businessContact method not publishedSAM registrationNot available
JESSIE WICKAlternate electronic businessContact method not publishedSAM registrationNot available
Registered industries
  • 325413 — In-Vitro Diagnostic Substance Manufacturing

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source

Related companies worth researching

Explore the customer, work and award-size evidence behind each match.

GLOBAL BIOCLINICAL

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
1 awards

SARTORIUS STEDIM NORTH AMERICA INC.

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
1 awards

10X GENOMICS, INC.

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
46 awards

CHONDREX, INC

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
1 awards

MCKESSON MEDICAL-SURGICAL INC.

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
2 awards

BECTON, DICKINSON AND COMPANY

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
2 awards
Data coverage and methodology

Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.

Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.

Keep your research moving

Save this company, track changes, and evaluate upcoming work against your targets.

Save to my research Find my fit